Holen Sie sich die Stockscreener-App
3.9247
5.56%
-0.2453
Schlusskurs vom Vortag:
$4.17
Offen:
$4.2
24-Stunden-Volumen:
2.34M
Relative Volume:
0.42
Marktkapitalisierung:
$1.44B
Einnahmen:
$4.09M
Nettoeinkommen (Verlust:
$-660.15M
KGV:
-1.7025
EPS:
-2.3053
Netto-Cashflow:
$-117.10M
1W Leistung:
-5.33%
1M Leistung:
+3.91%
6M Leistung:
-9.67%
1J Leistung:
+183.32%
1-Tages-Spanne:
$3.92
$4.23
1-Wochen-Bereich:
$3.92
$4.275
52-Wochen-Spanne:
$1.29
$6.75
Ataibeckley Inc Stock (ATAI) Company Profile
Firmenname
Ataibeckley Inc
Sektor
Branche
Telefon
1 929 207 2670
Adresse
C/O ATAI LIFE SCIENCES US, INC., NEW YORK
Compare ATAI vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATAI
Ataibeckley Inc
|
3.92 | 1.53B | 4.09M | -660.15M | -117.10M | -2.3053 |
VRTX
Vertex Pharmaceuticals Inc
|
427.18 | 108.54B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
712.38 | 75.59B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
786.32 | 50.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
294.33 | 40.45B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
314.25 | 32.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Ataibeckley Inc Stock (ATAI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-27 | Eingeleitet | Deutsche Bank | Buy |
| 2026-01-20 | Eingeleitet | Guggenheim | Buy |
| 2025-10-13 | Eingeleitet | Needham | Buy |
| 2025-07-29 | Eingeleitet | Oppenheimer | Outperform |
| 2024-11-18 | Bestätigt | H.C. Wainwright | Buy |
| 2024-04-03 | Hochstufung | Maxim Group | Hold → Buy |
| 2022-11-01 | Eingeleitet | Loop Capital | Buy |
| 2021-11-30 | Eingeleitet | Maxim Group | Buy |
| 2021-11-11 | Eingeleitet | ROTH Capital | Buy |
| 2021-10-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-09-01 | Eingeleitet | Jefferies | Buy |
| 2021-07-13 | Eingeleitet | Berenberg | Buy |
| 2021-07-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-13 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2021-07-13 | Eingeleitet | Citigroup | Buy |
| 2021-07-13 | Eingeleitet | Cowen | Outperform |
| 2021-07-13 | Eingeleitet | Credit Suisse | Outperform |
| 2021-07-13 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-07-08 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Ataibeckley Inc Aktie (ATAI) Neueste Nachrichten
These stocks are today’s movers: Fermi, AST SpaceMobile, Intel, Marvell, USA Rare Earth, Ataibeckley, and more - MSN
ATAI stock soars on track for best day on Trump psychedelics push and Wall Street cheers - MSN
AtaiBeckley Is Said to Explore Options for Main Psychedelic Drug - MSN
Is AtaiBeckley (ATAI) Redefining Its Psychedelic Strategy With Standalone EMP-01 Anxiety Data? - simplywall.st
10 Health Care Stocks With Whale Alerts In Today's SessionAbbVie (NYSE:ABBV), AtaiBeckley (NASDAQ:ATAI - Benzinga
Does AtaiBeckley’s (ATAI) EMP-01 Data Hint At A Scalable MDMA Therapy Platform? - Yahoo Finance
Ataibeckley: Anxiety drug cuts social phobia symptoms by 38% - MSN
ATAI Stock Price, Quote & Chart | ATAIBECKLEY INC (NASDAQ:ATAI) - ChartMill
Why Ataibeckley stock surged today - MSN
Atai Beckley N.V. (ATAI) Receives a Buy from H.C. Wainwright - The Globe and Mail
AtaiBeckley weighing options for lead psychedelic therapy: Bloomberg - MSN
Shroom stocks rise as Trump is said to sign executive order on psychedelic drug - MSN
Psychedelic stocks soar as Trump signs order to ease access - MSN
Small cap wrap: VivoPower, First Phosphate, ataiBeckley, Trillion Energy... - Proactive financial news
AtaiBeckley wins OVID Health Silver Award for patient partnership in psychedelic trials - Proactive Investors
Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research - MSN
AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research - Investing News Network
AtaiBeckley and PsyPAN win silver for trial participant input - Stock Titan
Enveric Biosciences surges over 90%, other psychedelic stocks soar in Monday pre-market: What's going on? - MSN
AtaiBeckley Inc.Common Stock (NQ: ATAI - The Chronicle-Journal
AtaiBeckley’s EMP-01 Data Strengthen Case For Psychedelic Anxiety Pipeline - Sahm
ATAI Stock Soars On Track For Best Day On Trump Psychedelics Push And Wall Street Cheers - Stocktwits
Finanzdaten der Ataibeckley Inc-Aktie (ATAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.78%
0.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):